Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
Yi ChenLuting LuoLushan ChenXiaoyun ZhengXiaozhu YangZhihong ZhengJing ZhengTingbo LiuTing YangJian-da HuPublished in: Journal of cancer research and clinical oncology (2022)
Patients with FL/DLBCL showed inferior treatment response and survival than those with pure FL and had a lower CR rate and PFS, but similar OS to those with DLBCL in the rituximab era.